av/celldex-therapeutics--big.svg

NASDAQ:CLDX

Celldex

  • Stock

20.71

−0.58%

−3.09

USD last updated 13/08 01:59:42

Last Close

23.80

12/08 20:39

Market Cap

2.41B

Beta: 2.11

Volume Today

599.89K

Avg: 647.39K

PE Ratio

−15.31

PFCF: −20.78

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-0159, a Phase I monoclonal antibody...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -1.2-1-0.8-0.6-0.4-0.22019-03-072020-08-062021-12-312023-08-082024-11-07

    Revenue (Estimate*)

    1M2M3M4M2019-03-072020-08-062021-12-312023-08-082024-11-07

    *Estimate based on analyst consensus